TOP STORIES

• REGULATORY DPP-4 Inhibitors, Remicade to Face Market Expansion Re-Pricing in FY2014 Revision
  January 23, 2014

• BUSINESS Azilva Remains No.1 in December “Mind Share” Ranking in GP, HP Markets
  January 22, 2014

• BUSINESS Sales Reps Vied over Questionnaire Transfers in Tasigna Trial, Boss OK’ed Incentive Program: Novartis
  January 21, 2014

• BUSINESS Novartis Sales Reps Transferred Patient Questionnaires in Investigator-Led Trial
  January 20, 2014

• BUSINESS Japan’s First SGLT-2 Inhibitor Suglat Approved: Astellas
  January 20, 2014

• REGULATORY More Manpower, Knowledge Necessary for Giving New Drugs World’s First Approval: PMDA Chief Executive
  January 17, 2014

• REGULATORY Varicella, Adult Pneumococcal Vaccines to Join Japan’s Routine Immunization Program in October
  January 16, 2014

• ORGANIZATION Generic Makers Likely to Disclose Payments to Medical Institutions from Early May
  January 15, 2014

• ORGANIZATION JPWA Chair Weighs Cartel Deal to Unify Tax Display Methods after Sales Levy Hike
  January 14, 2014

• REGULATORY Did Novartis Employees “Willfully” Use Rigged Data in Diovan Ads? Statute of Limitations Will Pose Hurdles to Chase Key Figure
  January 10, 2014

• ORGANIZATION Next Drug Price Revision Won’t Help Promote Generic Use, JGA President Says
  January 9, 2014

• REGULATORY MHLW Files Criminal Complaint against Novartis over Diovan Ads
  January 9, 2014

• BUSINESS Former Pfizer EPBU Head Matsumori Joins SBI Biotech as President
  January 8, 2014

• REGULATORY MHLW to File Criminal Complaint against Novartis Jan. 8
  January 8, 2014

• REGULATORY MHLW Economic Affairs Official Says Shakeout in Generic Sphere “Inevitable”
  January 7, 2014

• BUSINESS New Price Cut Rule for Long-Listed Products Blow to Drug Makers
  January 6, 2014

• ORGANIZATION New Price Cut for Long-Listed Products “Harsh,” Needs Follow-Up Review: FPMAJ Chair Naito
  January 1, 2014

• BUSINESS Takeda to End Development of TAK-875 Due to Liver Safety Concerns
  December 27, 2013

• BUSINESS Nissan Chemical Sues Seven Generic Companies over Livalo Patents
  December 27, 2013

• REGULATORY Chuikyo Approves Outline for NHI Price Reform Including New Rule for Long-Listed Drugs; Trial of Premium for New Drug Development to Continue
  December 26, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 205
• 206
• 207
• 208
• 209
• 210
• 211
• 212
• 213
• …
• Next ›
• 最終 »